Additionally, ocrelizumab has shown efficacy specifically in PPMS cases, offering a notable therapeutic option while other interventions for PPMS, are limited [141]
3 studies scored six, indicating medium-quality studies with a moderate risk of bias
Neurological & Mental Health Support Emerging animal research has indicated potential neuroprotective and mood-modulating effects of BPC-157, sparking interest among patients recovering from traumatic brain injuries, depression, or anxiety though this remains highly speculative at the clinical level
This material is for research only and is not intended for human consumption or clinical applications
More importantly, the FDAs own scientific assessments recommended against listing all seven substances.[36] Here is a closer look at four of the peptides the FDA reviewed which are particularly relevant for GPs
Not recommended for use in individuals with asthma due to the possibility of increasing its symptoms